# A Study of LY3541105 in Healthy and Overweight Participants

> **NCT05380323** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 206 (actual)

## Conditions studied

- Overweight
- Healthy

## Interventions

- **DRUG:** LY3541105
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05380323
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-10
- **Primary completion:** 2024-08-27
- **Final completion:** 2024-08-27
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380323, "A Study of LY3541105 in Healthy and Overweight Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05380323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*